Toward a Framework to Improve Diversity and Inclusion in Clinical Trials Proceedings of a Workshop (2025) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 77-82
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 77... ...
Appendix A Workshop Agenda TOWARD A FRAMEWORK TO IMPROVE DIVERSITY AND INCLUSION IN CLINICAL TRIALS A WORKSHOP National Academy of Sciences Building, 2101 Constitution Ave, NW Washington, DC 20418 MAY 20, 2024 WELCOME AND OPENING REMARKS 8:30 am FREDA LEWIS-HALL, Workshop Chair Former Executive Vice President and Chief Medical Officer (Retired) Pfizer VICTOR DZAU President National Academy of Medicine 77
|
From page 78... ...
• Explore collective approaches to overcome barriers to equitable and representative clinical trial participation. 9:00 am Panel Discussion with Audience Q&A Moderator: Martin Mendoza, Centers for Medicare & Medicaid Services RALPH CAMMACK Director of Research Wabanaki Public Health and Wellness QUITA HIGHSMITH Vice President and Chief Diversity Officer Genentech BRIAN RIVERS Director, Cancer Health Equity Institute Morehouse School of Medicine
|
From page 79... ...
11:00 am Panel Discussion with Audience Q&A Moderator: Carla Rodriguez-Watson, Reagan-Udall Foundation for FDA JAMIE BREWER Medical Oncologist and Clinical Team Lead Office of Oncologic Diseases Food and Drug Administration
|
From page 80... ...
12:45 pm Panel Discussion with Audience Q&A Moderator: Kathy Mickel, Society for Clinical Research Sites MEGAN COYLEWRIGHT Vice Chief of Cardiology Erlanger Health System AMY FlOWERS Director of Policy Research National Association of Community Health Centers
|
From page 81... ...
• Discuss collaborative opportunities for improving public awareness about the risks, benefits, and value of clinical trial participation.
|
From page 82... ...
82 IMPROVING DIVERSITY AND INCLUSION IN CLINICAL TRIALS 3:20 pm Panel Discussion with Audience Q&A Moderator: Michelle McMurry-Heath, BioTechquity Clinical STACEY ADAM Vice President, Science Partnerships Foundation for the National Institutes of Health MARY NWOKEDI-NWANERI Director, Diversity in Clinical Trials Pharmaceutical Research and Manufacturers of America NATALIA CHALMERS Chief Dental Officer Centers for Medicare & Medicaid Services GWEN DARIEN Executive Vice President, Patient Advocacy, Engagement, and Education Patient Advocate Foundation DECHANE DORSEY Executive Director, AdvaMed Accel AdvaMed MARY THANH HAI Deputy Director for Clinical, Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration 4:50 pm Closing Remarks FREDA LEWIS-HALL, Workshop Chair 5:00 pm Adjourn Workshop
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.